1C-SAPNP Trademark

Trademark Overview

On Thursday, April 24, 2025, a trademark application was filed for 1C-SAPNP with the United States Patent and Trademark Office. The USPTO has given the 1C-SAPNP trademark a serial number of 99152999. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, April 10, 2026. This trademark is owned by Uvax Bio LLC. The 1C-SAPNP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Vaccine research and development
1c-sapnp

General Information

Serial Number99152999
Word Mark1C-SAPNP
Filing DateThursday, April 24, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, April 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkSINGLE COMPONENT MULTILAYERED SELF ASSEMBLING PROTEIN NANOPARTICLES
Pseudo MarkONE COMPONENT MULTILAYERED SELF ASSEMBLING PROTEIN NANOPARTICLES
Pseudo MarkONE COMPONENT SELF ASSEMBLING PROTEIN NANOPARTICLES
Pseudo MarkSINGLE COMPONENT SELF ASSEMBLING PROTEIN NANOPARTICLES
Goods and ServicesVaccine research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code042
First Use Anywhere DateFriday, December 3, 2021
First Use In Commerce DateFriday, December 3, 2021

Trademark Owner History

Party NameUvax Bio LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDover, DE 19901
US

Trademark Events

Event DateEvent Description
Thursday, April 24, 2025NEW APPLICATION ENTERED
Thursday, April 24, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, October 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 22, 2025ASSIGNED TO EXAMINER
Monday, October 27, 2025NON-FINAL ACTION WRITTEN
Monday, October 27, 2025NON-FINAL ACTION E-MAILED
Monday, October 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 27, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 27, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 27, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 10, 2026NON-FINAL ACTION WRITTEN
Friday, April 10, 2026NON-FINAL ACTION E-MAILED
Friday, April 10, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

sapnp development research vaccine